Cipla withdrawing 5.8 lakh packet medicine
Cipla is recalling over 5.8 lakh packets of the drug used in the treatment of gastric ulcer from the US market.
- January 10, 2021, 5:32 PM IST
Why is the company bringing back medicines
Let us tell you that the company was built in the Kurchambh factory in Maharashtra After its manufacture, these medicines were sent to the associate unit in New Jersey, USA. According to the USFDA, due to being infected with other products, these medicines are being recalled.
Also read: Egg became cheaper by effect of bird flu, rate reached 3 rupees, check ratelistWhich medicines are being recalled
In addition, the report states that the medicinal element crosspovidone, NF was found to be infected with theophylline. According to the US regulator, the company is recalling 2,84,610 packets of 10mg capacity and 2,89,350 packets of 20mg. With this, the company is recalling 6,491 packets of Esomeprazole Magnesium of 40 mg capacity.
Let us tell you that the process of recalling these medicines started on December 17, 2020. The USFDA has classified it as a Class 2 recall. Let us know that its class 2 class recall process is started when the use of any medicine shows serious and adverse effects on the health of any person.